Author

Linda Hu

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Elizabeth Alexandra CooperiD· 2 shared Jessica TayloriD· 2 shared Katherine Elizabeth MasihiD· 2 shared Richard J. GilbertsoniD· 2 shared Amir Jassim· 1 shared Anarita Patrizi· 1 shared Anthony D. HilliD· 1 shared Arnold R. KriegsteiniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Elizabeth Alexandra CooperORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 25, 2025

Childhood brain tumours instruct cranial haematopoiesis and immunotolerance

Elizabeth Alexandra Cooper, David A Posner, Colin Y.C. Lee…·Richard J. Gilbertson

This study identifies a mechanism by which skull bone marrow-derived HSPCs and CD4+ T cells promote immunotolerance in childhood brain tumours, showing that antibody therapy targeting CSF cytokines can disrupt this process and induce tumour regression.

DOI 10.1101/2025.09.25.678472

mouseproteomics

𝕏 PostBluesky

Cancer BiologyCancer CellPeer-reviewedJun 26, 2025

Natural language processing charts transcriptome evolution to design combination cancer therapies

Amir Jassim, Birgit V. Nimmervoll, Sabrina Terranova…·Richard J. Gilbertson

This paper introduces RECODR, a computational pipeline that tracks transcriptome changes in cancer development and treatment to predict resistance mechanisms and design effective therapies.

15 citations

mousebulk RNA-seq

𝕏 PostBluesky